Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacy

J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e88-e90. doi: 10.1111/jdv.17722. Epub 2021 Oct 12.

Authors

V Schmidt^{1

2}, R Blum³, M Möhrenschlager¹

Affiliations

¹ Department of Dermatology, Hochgebirgsklinik Davos, Davos Wolfgang, Switzerland.
² Christine Kühne Center for Allergy Research and Education, Davos, Switzerland.
³ Department of Dermatology, Inselspital, University of Bern, Bern, Switzerland.

PMID: 34606112
DOI: 10.1111/jdv.17722

No abstract available

Publication types

Case Reports
Letter

MeSH terms

2019-nCoV Vaccine mRNA-1273*
Aged, 80 and over
Female
Humans
Pemphigoid, Bullous* / drug therapy
Polypharmacy

Substances

2019-nCoV Vaccine mRNA-1273